Back
ESC Premium Access

Do we reach the LDL-c goals in Familial hypercholesterolemiapatients under Eighteen Years Old? SAFEHEART (Spanish Familial Hypercholesterolemia Longitudinal Cohort Study) follow-up study

Session: Are we ever going to get to lipid goals?
Topic: Epidemiology, lipids
Speaker: Doctor A. Saltijeral Cerezo (Madrid, ES)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Adriana Saltijeral Cerezo

Del Tajo University Hospital, Madrid (Spain)
0 follower

6 more presentations in this session

Improvement of LDL-cholesterol goal attainment in high-risk patients in Europe and Middle East between 2008/09 and 2013/14 - Results of DYSIS and DYSIS II CHD

Speaker: Doctor A. Gitt (Ludwigshafen, DE)

Access
Abstract
Slides
Like
Thumbnail

Statin use and dose by low-density lipoprotein cholesterol level in U.S. commercially insured patients with type 2 diabetes

Speaker: Doctor R. Rosenson (New York, US)

Access
Abstract
Slides
Like
Thumbnail

Still high prevalence of persistent lipid abnormalities among patients with ACS or stable CHD despite chronic statin therapy in 2014: results of DYSIS II ACS and CHD

Speaker: Doctor A. Gitt (Ludwigshafen, DE)

Access
Abstract
Slides
Like
Thumbnail

Modeling lipid-lowering therapy intensification in the real world: how many patients with atherosclerotic cardiovascular disease would need a PCSK9 inhibitor?

Speaker: Doctor C. Cannon (Boston, US)

Access
Abstract
Slides
Like
Thumbnail

Residual atherosclerotic cardiovascular disease risk in statin-treated adults: the multi-ethnic study of atherosclerosis

Speaker: Doctor N. Wong (Irvine, US)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Are we ever going to get to lipid goals?

Speakers: Doctor A. Saltijeral Cerezo, Doctor A. Gitt, Doctor R. Rosenson, Doctor A. Gitt, Doctor C. Cannon...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources